EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry

Andrea Giacomelli iD, Nicolò Capra iD, Riccardo Lolatto, Roberta Gagliardini, Tommaso Clemente iD, Leonardo Calza, Carlo Torti, Filippo Lagi, Chiara Fornabaio, Giulia Marchetti iD, Giancarlo Orofino, Vincenzo Spagnuolo iD und 1 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Andrea Giacomelli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Drug Resistance, Viral, Drug Resistance, Multiple, Viral. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ViiV Healthcare, Gilead Sciences, Merck Sharp & Dohme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with human immunodeficiency virus (HIV) (PWH) with 4-drug class resistance (4DR) had a higher risk of death than non-4DR PWH, primarily due to lower CD4 cell counts. The priority for this vulnerable population is achieving virological control to enable immune recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsDrug Resistance, ViralDrug Resistance, Multiple, ViralHumansMaleCD4 Lymphocyte CountFemaleAdultRegistriesMiddle AgedCohort Studies

Stichwörter der Autor:innen

deathheavily treatment experiencedimmune suppressionmultidrug resistanceoutcome

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Milan, Italy.
  • III Infectious Diseases Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
  • IRCCS Ospedale San Raffaele, Infectious Diseases Unit, Milan, Italy.
  • Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
  • Department of Medical and Surgical Sciences, Unit of Infectious Diseases, S. Orsola Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Infectious Diseases Unit, Agostino Gemelli; University Hospital, Rome, Italy.

ORCID-Profile: Andrea Giacomelli, Nicolò Capra, Tommaso Clemente, Giulia Marchetti, Vincenzo Spagnuolo

Förderung

  • ViiV Healthcare
  • Gilead Sciences
  • Merck Sharp & Dohme
  • Janssen-Cilag
  • PRESTIGIO registry
  • Janssen–Cilag

Zitieren

APA

Giacomelli, A., Capra, N., Lolatto, R., Gagliardini, R., Clemente, T., Calza, L., Torti, C., Lagi, F., Fornabaio, C., Marchetti, G., Orofino, G., Spagnuolo, V., & for PRESTIGIO Study Group (2025). All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf421

Vancouver

Giacomelli A, Capra N, Lolatto R, Gagliardini R, Clemente T, Calza L, et al. All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf421

BibTeX
@article{Giacomelli2025,
  author = {Giacomelli, Andrea and Capra, Nicolò and Lolatto, Riccardo and Gagliardini, Roberta and Clemente, Tommaso and Calza, Leonardo and Torti, Carlo and Lagi, Filippo and Fornabaio, Chiara and Marchetti, Giulia and Orofino, Giancarlo and Spagnuolo, Vincenzo and for PRESTIGIO Study Group, for PRESTIGIO Study Group},
  title = {All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf421}
}
Kostenlos starten →